Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women

Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women

Abstract Background In adults with febrile urinary tract infection (fUTI), data on optimal treatment duration in patients other than non-pregnant women without comorbidities are lacking. Methods A randomized placebo-controlled, double-blind, non-inferiority trial among 35 primary care centers and 7...

Full description

Bibliographic Details
Main Authors: Cees van Nieuwkoop, Willize E. van der Starre, Janneke E. Stalenhoef, Anna M. van Aartrijk, Tanny J. K. van der Reijden, Albert M. Vollaard, Nathalie M. Delfos, Jan W. van ’t Wout, Jeanet W. Blom, Ida C. Spelt, Eliane M. S. Leyten, Ted Koster, Hans C. Ablij, Martha T. van der Beek, Mirjam J. Knol, Jaap T. van Dissel
Format: Article
Language:English
Published: BMC 2017-04-01
Series:BMC Medicine
Subjects:
Antibiotic therapy
Treatment duration
Pyelonephritis
Urinary tract infection
Online Access:http://link.springer.com/article/10.1186/s12916-017-0835-3

Internet

http://link.springer.com/article/10.1186/s12916-017-0835-3

Similar Items